908 Devices Inc (MASS) Options

$MASS: Repligen purchases sending $MASS

Now at $3.30


We've announced that @Repligen has purchased our bioprocessing PAT portfolio including our MAVERICK, MAVEN, REBEL & ZipChip devices. We are now fully focused on serving vital health and safety applications with our newly expanded handheld device portfolio. https://t.co/8ayBstxGDp pic.twitter.com/GcOpPEMsvQ— 908 Devices (@908Devices) March 4, 2025


Nice moves but still a Net Operating Loss so I dont know if this will stick around.
Gotta get those expenses under control.


GO $MASS

Transaction Terms and Advisors

The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella Weinberg Partners is acting as financial advisor and Paul Hastings LLP is serving as legal counsel to 908 Devices Inc.
https://www.businesswire.com/news/home/20250304869460/en

Transaction Terms and Advisors

The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella Weinberg Partners is acting as financial advisor and Paul Hastings LLP is serving as legal counsel to 908 Devices Inc.
https://www.businesswire.com/news/home/20250304869460/en

MASS ready for 3.40

MASS MONSTER

MASS GOING TO BE MASSIVE

Invisible works $2.42 + 20%

MASS, new 52 week low

MASS new 52 low

MASS new 52=week high

MASS new 52 week low

MASS new 52 week low

MASS 10Q due March 5

From that awful Cathie Wood
908 Devices (MASS)
icon-rise-1
22%
Shares of 908 Devices traded up ~22% on Tuesday after the company released5 its second-quarter results in which revenues rose 9% on a year-over-year basis, surprising on the high side of expectations. 908 Devices is a life sciences tools company that miniaturizes mass spectrometry to decentralize chemical and biomolecular analyses.